因此，积极探索既能克服CXR缺点，又能对新生儿肺疾病作出准确诊断、且易为临床医师掌握的新技术新方法尤为重要。经过十余年的研究和临床应用，肺脏疾病超声诊断的“禁区”已被打破，研究证实肺脏超声 (LUS) ...

A study undertaken by AstraZeneca reflects that AI-integrated CXR could be used as a preliminary step before low-dose ...